Midlife anticholinergic drug use, risk of Alzheimer's disease, and brain atrophy in community-dwelling older adults

INTRODUCTION: We examined how long-term anticholinergic (AC) drug use beginning at midlife affects risk of Alzheimer's disease (AD) and rates of brain atrophy in cognitively normal older adults. METHODS: We followed 723 individuals (mean baseline age 52.3 years; mean follow-up interval 20.1 yea...

Descripción completa

Detalles Bibliográficos
Autores principales: Chuang, Yi-Fang, Elango, Palchamy, Gonzalez, Christopher E., Thambisetty, Madhav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Featured Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651434/
https://www.ncbi.nlm.nih.gov/pubmed/29067353
http://dx.doi.org/10.1016/j.trci.2017.06.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651434/
https://www.ncbi.nlm.nih.gov/pubmed/29067353
http://dx.doi.org/10.1016/j.trci.2017.06.004

Ejemplares similares